title: Effect of chemotherapy on whole-blood cytokine responses to Mycobacterium tuberculosis antigens in a small cohort of patients with pulmonary tuberculosis.
abstract: The development of genomic and proteomic tools has enabled studies that begin to characterize the molecular targets of an effective host immune response to Mycobacterium tuberculosis, including understanding the specific immune responses associated with tuberculosis (TB) disease progression, disease resolution, and the development of latency. One application of such tools is the development of diagnostic reagents and assays useful as a test of cure. Such a test could be of considerable importance for the evaluation of new therapeutics. We and others have previously described immunodominant proteins of M. tuberculosis, including both vaccine and diagnostic candidates. In the present study, we describe the changes in immune responses to a panel of 71 M. tuberculosis antigens in six patients during the course of therapy. The levels of six cytokines were measured in 24-h whole-blood assays with these antigens, revealing that gamma interferon (IFN-γ), tumor necrosis factor (TNF), and interleukin-10 (IL-10) were differentially regulated in response to a subset of antigens. Therefore, measuring the production of these three cytokines in response to a panel of carefully selected M. tuberculosis proteins during the course of TB therapy might be a promising path toward the development of a test of cure and warrants further validation in larger cohorts of pulmonary TB patients.
authors.affiliation: Infectious Disease Research Institute, 1124 Columbia Street, Ste. 400, Seattle, WA 98104, USA.
authors.forename: Sylvie
authors.initials: S
authors.lastname: Bertholet
authors.forename: David J
authors.initials: DJ
authors.lastname: Horne
authors.forename: Elsa M
authors.initials: EM
authors.lastname: Laughlin
authors.forename: Margery
authors.initials: M
authors.lastname: Savlov
authors.forename: Ines
authors.initials: I
authors.lastname: Tucakovic
authors.forename: Rhea N
authors.initials: RN
authors.lastname: Coler
authors.forename: Masahiro
authors.initials: M
authors.lastname: Narita
authors.forename: Steven G
authors.initials: SG
authors.lastname: Reed
mesh_terms: D000328:Adult; D000942:Antigens, Bacterial / Q000276:immunology*; D000995:Antitubercular Agents / Q000008:administration & dosage*; D001769:Blood / Q000276:immunology*; D016207:Cytokines / Q000378:metabolism*; D005260:Female; D006801:Humans; D007963:Leukocytes, Mononuclear / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D009169:Mycobacterium tuberculosis / Q000276:immunology; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000276:immunology*
chemical_list: D000942:Antigens, Bacterial; D000995:Antitubercular Agents; D016207:Cytokines; C072681:Mycobacterium tuberculosis antigens